Results for tag: "Burkholderia Drug"

The Burkholderia Drug market is a subset of the Infectious Diseases Drugs market, focusing on treatments for infections caused by the Burkholderia bacteria. These infections can range from mild to life-threatening, and can affect the lungs, urinary tract, and other parts of the body. The drugs used to treat these infections are typically antibiotics, such as carbapenems, cephalosporins, and fluoroquinolones. In addition, some drugs are used to treat the symptoms of Burkholderia infections, such as fever, cough, and difficulty breathing. The Burkholderia Drug market is highly competitive, with many companies offering treatments for these infections. Some of the major players in the market include Merck & Co., Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Other companies, such as Cipla, Lupin, and Sun Pharmaceuticals, also offer treatments for Burkholderia infections. Show Less Read more